Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cholestech waiver

This article was originally published in The Gray Sheet

Executive Summary

Cholestech is granted a waiver under the Clinical Laboratory Improvement Amendments July 12 for its Lipid Profile ALT test panel for simultaneously measuring cholesterol and liver damage. The status makes the product accessible to doctors' offices and health clinics for point-of-care testing. Inverness Medical agreed to acquire Cholestech in June (1"The Gray Sheet" June 11, 2007, p. 9)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025017

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel